BRAFTOVI HARD CAPSULE 50MG
Product details
Registration number: SIN16825P
Classification: Prescription Only
Active ingredients: Encorafenib
Strength: 50mg
Dosage form: CAPSULE
Route: ORAL
Registrant: PIERRE FABRE SINGAPORE PTE. LTD.
ATC code: L01EC03
HSA approval date: 19 July 2023
Manufacturer(s):
- Ardena U.S. LLC
- ALMAC Pharma Services Limited (Primary and Secondary Packager)
- Pierre Fabre Médicament Production (PFMP) (Primary and Secondary Packager)
Manufacturing country/countries: UNITED STATES; FRANCE; UNITED KINGDOM
What are the HSA registration number and classification for BRAFTOVI HARD CAPSULE 50MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16825P
Classification: Prescription Only
What active ingredients and strength are recorded for BRAFTOVI HARD CAPSULE 50MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Encorafenib
Strength: 50mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for BRAFTOVI HARD CAPSULE 50MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: CAPSULE
Route: ORAL
Who is the recorded registrant for BRAFTOVI HARD CAPSULE 50MG?
According to the HSA dataset updated 7 August 2026:
Registrant: PIERRE FABRE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for BRAFTOVI HARD CAPSULE 50MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Ardena U.S. LLC
- ALMAC Pharma Services Limited (Primary and Secondary Packager)
- Pierre Fabre Médicament Production (PFMP) (Primary and Secondary Packager)
Manufacturing country/countries: UNITED STATES; FRANCE; UNITED KINGDOM
Where can I look up BRAFTOVI HARD CAPSULE 50MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16825P or the exact product name BRAFTOVI HARD CAPSULE 50MG. The general register link does not preselect this product.
What are the source dates for this BRAFTOVI HARD CAPSULE 50MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this BRAFTOVI HARD CAPSULE 50MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16825P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)